TABLE 2.
MICs for coagulase-negative staphylococci
Drug | MIC (μg/ml)
|
|||||
---|---|---|---|---|---|---|
Methicillin-resistant strains (n = 60)
|
Methicillin-susceptible strains (n = 67)
|
|||||
Range | 50% | 90% | Range | 50% | 90% | |
LBM415 | ≤0.06-2.0 | 1.0 | 2.0 | 0.125-4.0 | 1.0 | 2.0 |
Ciprofloxacin | ≤0.06->16.0 | 8.0 | >16.0 | ≤0.06->16.0 | 0.125 | 4.0 |
Levofloxacin | ≤0.06->16.0 | 4.0 | 8.0 | ≤0.06-16.0 | 0.125 | 4.0 |
Gatifloxacin | 0.03-4.0 | 1.0 | 2.0 | 0.03-4.0 | 0.06 | 1.0 |
Moxifloxacin | ≤0.016-8.0 | 1.0 | 2.0 | ≤0.016-2.0 | 0.03 | 0.5 |
Vancomycin | 0.5-2.0 | 2.0 | 2.0 | 0.25-2.0 | 1.0 | 2.0 |
Teicoplanin | 0.5->16.0 | 4.0 | 8.0 | 0.125-16.0 | 1.0 | 8.0 |
Oritavancin | 0.5-4.0 | 2.0 | 2.0 | 0.25-4.0 | 2.0 | 2.0 |
Linezolid | 1.0-2.0 | 1.0 | 2.0 | 1.0-4.0 | 1.0 | 2.0 |
Ranbezolid | ≤0.06-4.0 | 0.25 | 1.0 | ≤0.06-1.0 | 0.125 | 0.5 |
Daptomycin | 0.25-1.0 | 0.5 | 0.5 | 0.125-1.0 | 0.5 | 0.5 |
Quinupristin-dalfopristin | 0.125-1.0 | 0.125 | 0.5 | ≤0.06-1.0 | 0.125 | 0.5 |